Djibouti vs South Africa: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Djibouti
1.0%
in 2024
South Africa
1.0%
in 2024
Djibouti rank
34th
South Africa rank
34th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Djibouti
- South Africa
How they compare
Djibouti currently reports 1.0% against 1.0% in South Africa, a difference of 0.0%.
Across all 10 years both countries report, South Africa has been ahead every year.
Djibouti ranks 34th and South Africa ranks 34th of 246 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Djibouti | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.0% | 1.3% | 0.3% | South Africa |
| 2020s | 1.0% | 1.1% | 0.1% | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Djibouti or South Africa?
- Djibouti, at 1.0% against 1.0% in South Africa as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Djibouti and South Africa?
- 0.0%, with Djibouti ahead.
- How many years of comparable data are there for Djibouti and South Africa?
- 10 years are reported by both, from 2015 to 2024.
- How do Djibouti and South Africa rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Djibouti ranks 34th and South Africa ranks 34th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.